Tirzepatide Significantly Reduces Sleep Disruptions

The dual GIP/GLP-1 agonist is the first drug to show benefit in patients with obstructive sleep apnea.
Medscape Medical News

source https://www.medscape.com/viewarticle/tirzepatide-significantly-reduces-sleep-disruptions-2024a1000bm1?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

Heart Failure Care Outside of ICU Can Lower Cost